Skip to main content

Table 2 The panel of silica NFs used for the case study to assess the performance of the GRACIOUS oral IATA to support grouping of NFs

From: Grouping of orally ingested silica nanomaterials via use of an integrated approach to testing and assessment to streamline risk assessment

 

Crystallinity

Synthesis method

Surface

Treatments

Shape

Specific surface area

(BET, m2/g)

Constituent particle size

(nm, average ± SD) by Manufacturers

Constituent particle size

(nm, average ± SD) experimentally measured

NM-200

Amorphous

Wet

(precipitation)

None

Spheroidal

189

14 ± 7

20.7 ± 6.2

NM-203

Amorphous

Thermal (pyrogenesis)

None

Spheroidal

203

13 ± 6

13.3 ± 4.1

Silica-Std

Amorphous

Wet

(colloidal)

None

Spheroidal

209

10

10.0 ± 2.1

Silica-Silane

Amorphous

Wet

(colloidal)

Surface modified with glycerol-propyl moieties from alkyl-tri-alkoxysilanes

Spheroidal

216

10

12.1 ± 2.4

Silica-Al

Amorphous

Wet

(colloidal)

Surface modification with Na-aluminate

Spheroidal

175

11

13.3 ± 4.1

MCM-60

Mesoporous

Wet

(colloidal)

None

Spheroidal

1647

60 ± 10

69.5 ± 12.8

MCM-170

Mesoporous

Wet

(colloidal)

None

Spheroidal

1111

165 ± 21

151.2 ± 71.0

  1. The information provided includes both basic PC characteristics and synthesis routes of the different silica NFs as described by the manufacturers. The last column refers to the TEM size analysis of constituent particles in water as experimentally provided in the work. The obtained data are compared to the manufacturers’ values